Amrutanjan Health (AMRUTANJAN) | Stock Overview & Key Data
Amrutanjan Health Performance Comparison
Stock Range
Today's Range
Low: ₹714.50
High: ₹726.45
on October 3, 2025
52 Week Range
Low: ₹544.10
High: ₹842.90
on April 30, 2025
on January 13, 2025
All-Time High: ₹1,024.55 on November 8, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR21.2B
EPS
18.86
P/E Ratio (TTM)
37.88
Forward P/E
N/A
P/B Ratio
6.32
PEG Ratio
0.48
Div. Yield
0.64%
ROE
15.56%
Beta
0.392
Debt to Equity
0.64
Financial Highlights
Profitability
Gross Margin
47.48%
Operating Margin
7.36%
Profit Margin
11.80%
Returns and Earnings
Return on Assets (TTM)
12.06%
Return on Equity (TTM)
15.56%
EBITDA
INR807.5M
Net Income (TTM)
INR545.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR159.97
Quarterly Revenue Growth (YoY)
12.30%
Quarterly Earnings Growth (YoY)
80.10%
Dividend Information
Last 12-Month Dividend
₹4.60
Current Dividend Yield
0.64%
3-Year Average Dividend Yield
0.22%
3-Year Average Annual Dividend
₹4.60
3-Year Total Dividends
₹13.80
Ex-Dividend Date
February 18, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Amrutanjan Health AMRUTANJAN | 21.19B Small-cap | -4.47% | -0.83% | -1.58% | 10.99% | -0.84% | -7.07% | -1.11% | 70.45% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.56% | 4.66% | -1.86% | -3.66% | -13.43% | -14.34% | 71.30% | 219.01% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | -4.58% | -6.29% | -16.72% | 2.89% | -5.98% | 5.24% | 52.85% | 79.00% |
| Suven Life Sciences SUVEN | 48.20B Small-cap | -6.65% | -0.56% | -18.38% | 69.66% | 61.86% | 45.66% | 184.80% | 304.79% |
| Sequent Scientific SEQUENT | 48.13B Small-cap | -8.42% | 9.29% | -3.35% | 37.17% | 0.89% | -10.14% | 69.59% | 19.72% |
| Aarti Drugs AARTIDRUGS | 44.55B Small-cap | -5.64% | 3.08% | 3.92% | 42.25% | 7.15% | -5.48% | -1.60% | -50.42% |
Ownership & Short Interest
Insider Ownership
53.72%
Institutional Ownership
12.76%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
17K
Average 90-Day Volume
25K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AMRUTANJAN's 52-week high and low?
- In the last 52 weeks, Amrutanjan Health reached a high of ₹842.90 (on January 13, 2025) and a low of ₹544.10 (on April 30, 2025).
- What is the market cap and P/E ratio for AMRUTANJAN?
- Curious about Amrutanjan Health's size and valuation? Its market capitalization stands at 21.19B. When it comes to valuation, the P/E ratio (trailing twelve months) is 37.88, and the forward P/E (looking ahead) is N/A.
- Does AMRUTANJAN pay dividends? If so, what's the yield?
- Yes, Amrutanjan Health is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.64%, and the company has paid an average of ₹4.60 per share annually over the past 3 years.
- Who are Amrutanjan Health's main competitors or similar companies to consider before investing?
When looking at Amrutanjan Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -14.34% 71.30% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 5.24% 52.85% Suven Life Sciences
SUVEN48.20B Healthcare Drug Manufacturers - Specialty & Generic 45.66% 184.80% Sequent Scientific
SEQUENT48.13B Healthcare Drug Manufacturers - Specialty & Generic -10.14% 69.59% Aarti Drugs
AARTIDRUGS44.55B Healthcare Drug Manufacturers - Specialty & Generic -5.48% -1.60% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Amrutanjan Health Care Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Amrutanjan Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.56%, the Debt to Equity ratio from the most recent quarter is 0.64, and its Gross Profit Margin stands at 47.48%.
- What is the recent revenue and earnings growth for AMRUTANJAN?
- Looking at Amrutanjan Health's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.30%, and quarterly earnings saw a YoY growth of 80.10%.
- How much of AMRUTANJAN stock is held by insiders and institutions?
- Wondering who owns Amrutanjan Health stock? Company insiders (like executives and directors) hold about 53.72% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.76%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.